• APEX2 Proximity Labeling Reveals Pef1’s Role in DNA Repair a

  2026-05-09

  This study introduces APEX2-biotin phenol-mediated proximity labeling in Schizosaccharomyces pombe to systematically map the protein interaction landscape of the autophagy- and lifespan-regulating kinase Pef1, an ortholog of human CDK5. The findings uncover previously unrecognized Pef1 functions in DNA damage response and autophagosome expansion, establishing a framework for dissecting dynamic kinase interactomes in vivo.

• Patient-Derived Gastric Cancer Assembloids for Drug Response

  2026-05-08

  This study introduces a patient-derived gastric cancer assembloid system integrating matched tumor organoids with stromal cell subpopulations, achieving a more physiologically relevant tumor microenvironment than traditional models. The approach reveals critical influences of stromal cells on gene expression and drug response, supporting improved preclinical testing and personalized therapy development.

• Sulfaphenazole: Precision CYP2C9 Inhibition for Translationa

  2026-05-08

  Explore the mechanistic and translational significance of Sulfaphenazole as a selective CYP2C9 inhibitor, uncovering its roles in vascular function, oxidative stress reduction, and advanced wound healing. This article bridges the gap between molecular insight and strategic application, offering protocol recommendations and a forward-looking perspective for translational researchers.

• Lycopene Counters Deoxynivalenol-Induced Gut Barrier Damage

  2026-05-07

  This study demonstrates that lycopene effectively mitigates deoxynivalenol-induced intestinal barrier dysfunction and NLRP3 inflammasome activation in IPEC-J2 cells by targeting the ERK pathway. The findings offer mechanistic insight into the potential of dietary antioxidants to counteract mycotoxin-induced gut inflammation and epithelial injury.

• ATS-9R: Transforming Adipose Gene Silencing in Metabolic Dis

  2026-05-07

  This thought-leadership article explores how ATS-9R (Adipocyte-targeting sequence-9-arginine) redefines targeted gene delivery in metabolic disease research. By bridging mechanistic understanding with translational guidance, we examine prohibitin-mediated endocytosis, the unique workflow advantages of ATS-9R, and its translational promise for obesity-associated inflammation and insulin resistance models. Drawing on recent peer-reviewed evidence and expert workflow insights, this piece positions APExBIO’s ATS-9R as a pivotal tool for advancing adipocyte-focused therapeutics.

• Metabolic Enhancement of Ferroptosis and Cuproptosis in Tumo

  2026-05-06

  This article examines a recent metabolic intervention strategy that synchronously sensitizes tumor cells to ferroptosis and cuproptosis, thereby enhancing anti-tumor immunity. The study introduces a nanosystem targeting glycolysis and NAD+ metabolism, offering new mechanistic insights and practical routes for regulated cell death-based cancer therapy.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-05-06

  This study introduces a novel glabridin-gold(I) complex (6d) that synergistically targets thioredoxin reductase (TrxR) and MAPK pathways to enhance antitumor immunity while mitigating immunosuppression in liver cancer. The findings offer mechanistic insight into dual-pathway modulation and highlight prospects for improved combination immunotherapy strategies.

• L-Ornithine (B8919): Mechanistic Insights for CNS-Liver Rese

  2026-05-05

  Explore the multifaceted role of L-Ornithine in CNS-liver axis research, with new mechanistic insights from recent studies. This article highlights its value in advanced amino acid metabolism research and practical assay design.

• GANT61: GLI Inhibitor Workflows for Tumor Growth Suppression

  2026-05-05

  Leverage GANT61, a selective GLI inhibitor from APExBIO, to dissect Hedgehog pathway signaling, overcome immunotherapy resistance, and suppress tumor growth in advanced cancer models. This guide provides evidence-backed protocols, advanced troubleshooting, and actionable insights that translate the latest bench research into practical workflows.

• Indazole/Indole Glucagon Receptor Antagonists: Synthesis & F

  2026-05-04

  This study reports a novel series of indazole- and indole-based glucagon receptor antagonists with potent in vitro and in vivo activity. Through systematic structure–activity relationship (SAR) studies, the team identified orally active compounds that effectively reduce glucagon-induced hyperglycemia, offering promising leads for type 2 diabetes therapy.

• Caspase-3 Colorimetric Assay Kit: Practical Workflow Guidanc

  2026-05-04

  The Caspase-3 Colorimetric Assay Kit (SKU: K2008) offers a sensitive, rapid solution for quantifying DEVD-dependent caspase-3 activity in apoptosis assays. It is best suited for apoptosis, caspase signaling pathway, and neurodegenerative disease research where robust, reproducible caspase activity measurement is required. This kit should not be used in contexts requiring multiplexed or in vivo detection, or where detailed mechanistic insight beyond DEVD-pNA substrate cleavage is needed.

• Bay 11-7821 in Cancer and Inflammatory Signaling Pathway Res

  2026-05-03

  Bay 11-7821 (BAY 11-7082) is redefining precision targeting of the NF-κB pathway, empowering advanced cancer research and immune modulation. Discover optimized workflows, troubleshooting strategies, and translational insights to maximize its impact in apoptosis regulation and inflammation studies.

• tFUS Suppresses Post-Stroke Neuroinflammation via SHP2 Pathw

  2026-05-02

  This study demonstrates that transcranial focused ultrasound stimulation (tFUS) reduces NLRP3-mediated neuroinflammation following ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 signaling pathway in microglia. These findings establish a mechanistic basis for targeting SHP2 in neuroinflammation and suggest new avenues for translational stroke research.

• Lipoamino Bundle LNPs Optimize mRNA Delivery to Immune Cells

  2026-05-01

  This study introduces lipoamino bundle lipid nanoparticles (LNPs) engineered for highly efficient mRNA transfection of dendritic cells and macrophages, with pronounced spleen targeting in vivo. The findings support advances in mRNA delivery technologies, relevant for immunotherapy and vaccine development.

• Azithromycin: Macrolide Antibiotic Workflows for Research Pr

  2026-05-01

  Azithromycin, a flagship macrolide antibiotic from APExBIO, empowers researchers with robust workflows for bacterial infection models, resistance profiling, and trypanosomosis studies. This article distills evidence-backed protocols, troubleshooting insights, and innovative applications to unlock reproducible results and actionable data.

7939 records 16/530 page Previous Next First page 上5页 1617181920 下5页 Last page